Over the last decade, the evidence linking obesity to impaired reproductive function has grown. In this article, we review this evidence and discuss the underlying pathophysiology.
INTRODUCTION
Over half of reproductive age women and men are overweight or obese. Obesity plays a role in a myriad of health problems, including those of the reproductive system. Compared with normal-weight women, obese women are less likely to achieve clinical pregnancy or live birth after treatment with assisted reproductive technologies (ART) or to achieve pregnancy spontaneously. Obesity has also been associated with increased risk for miscarriage and adverse pregnancy outcomes. Many mechanistic details responsible for subfertility in obese women remain elusive. What is known is that the reproductive abnormalities associated with obesity are likely the result of cumulative effects of obesity on the hypothalamic-pituitary-ovarian (HPO) axis, the oocyte, as well as the endometrium (Fig. 1 ). Here we review what is known about these effects.
Hypothalamic-pituitary-ovarian axis
Obese women are twice as likely as normal-weight women to have irregular menses [1] , due in part to obesity's effects on the HPO axis. Adipose tissue takes part in the metabolism of sex steroids, and central obesity impairs reproduction even in the absence of polycystic ovarian syndrome (PCOS), a common condition characterized by hyperandrogenism, anovulation, and insulin resistance [2] . The insulin resistance and hyperinsulinemia often associated with obesity reduce hepatic production of steroid hormone binding globulin, leading to hyperandrogenemia [1] . Lower steroid hormone binding globulin and increased peripheral aromatization of androgens in adipose tissue result in higher free circulating estrogen levels, which may lead to increased negative feedback on the hypothalamic pituitary axis [3] . Resultant increases in gonadotropin releasing hormone and luteinizing hormone (LH) pulse frequency, and decreased follicle stimulating hormone (FSH) secretion are noted along with hampered ovarian follicular recruitment and ovulation [4] .
The Study of Women's Health across the Nation [5] , a cohort study of 848 women who provided daily urinary samples, observed longer follicular phases (P < 0.0001), shorter luteal phases (P ¼ 0.006), and lower FSH, luteinizing hormone, and progesterone metabolites in women with a BMI greater than 25 kg/m 2 . These findings suggest a shortened luteal phase may be important in subfertility seen among obese ovulatory women [6] . In a follow-up study of obese ovulatory women compared with nonobese ovulatory controls, Jain et al. [7] demonstrated that the obese cohort secreted luteinizing hormone of similar pulse frequency, but significantly lower amplitude that is different than the pattern noted in anovulatory women with PCOS. Further work suggests partial recovery of luteal function after weight loss from bariatric surgery [8] . Adipokines, cytokines secreted by adipose, associated with the regulation of the HPO axis, such as leptin, adiponectin, and resistin, have been identified and likely contribute to the menstrual cycle pathology noted above [9] .
The ovary or the endometrium: a debate
Although obesity's influence on the HPO axis may influence subfertility in ovulating obese women, obese women undergoing in-vitro fertilization in which exogenous gonadotropins are used to recruit ovarian follicles also have lower chances of conception than nonobese women [6, 10, 11] . In a recent study by Luke et al. [12] , using the Society for Assisted Reproductive Technologies database, a total of 152 500 ART cycles were evaluated and stratified based on BMI and autologous versus donor oocytes.
KEY POINTS
Obese women are less likely to achieve clinical pregnancy or live birth after treatment with ART or to achieve pregnancy spontaneously.
Obese women have derangements in the HPO axis.
Oocyte quality may be diminished in obese women.
Endometrial receptivity is likely impaired in obese women.
Male obesity contributes to impaired reproductive function independently and in combination with female obesity. The study [12] demonstrated a statistically significant reduction in clinical intrauterine pregnancy and live birth rates in obese women using autologous oocytes. This suggests that apart from HPO dysfunction, obesity also poses direct pathology at the level of the ovary or the endometrium. There are likely components of obesity that affect these tissues directly, but because steroid hormone production from the ovary induces change in the endometrium, it is difficult to tease out which reproductive tissue is harmed more by obesity, the ovary or the endometrium. The donor oocyte model has been used to address this question, although there are conflicting results. In this model embryos created from donated oocytes from young, healthy women are transferred into obese women. This model theoretically allows one to look specifically at the endometrium as an independent variable. A recent meta-analysis compiled data from six centers totalling 4758 women investigating the impact of donor oocyte recipient obesity on pregnancy [13 & ]. This analysis found no difference between obese versus nonobese women using donor oocytes in chance of pregnancy [relative risk (RR): 0.98, 95% confidence interval (CI): 0.83-1.15], embryo implantation (RR: 0.93, 95% CI: 0.8-1.07), miscarriage (RR: 1.12, 95% CI: 0.83-1.50), or live birth (RR: 0.91, 95% CI: 0.65-1.27). Shortly after this meta-analysis was published, a larger study from a single center in Spain compiling data from 9587 women using donor oocytes did find significantly decreased implantation, pregnancy, and live birth rates with increasing obesity, but no difference in miscarriage [14 & ]. Authors from both studies conclude that obesity likely impacts reproductive function at multiple levels -including the endometrium and the ovary.
Impaired reproductive function
The ovarian follicle, the oocyte and the embryo Because women are born with a finite number of oocytes, the impact of obesity on this cell line is of particularly interest in reproductive medicine. Obesity alters ovarian follicular fluid composition, oocyte metabolism and function of cells supporting oocyte and follicle development -granulosa cells, cumulus cells and theca cells [15] . Serum free fatty acids are elevated in obesity and increased ovarian free fatty acid concentrations are associated with poor morphology of the cumulus-oocyte complex which may affect subsequent oocyte developmental competence, and subsequent embryo quality [16] [17] [18] . Robker et al. [18] have demonstrated that obese women exhibit an altered ovarian follicular environment, demonstrating increased levels of insulin, glucose, C-reactive protein and lactate; increased androgen activity; and decreased human chorionic gonadotropin levels .
How changes in the ovarian follicle impact overall ovarian function or ovarian aging is unknown, but it is clear that obesity is associated with oocyte abnormalities. In 2011, Shah et al. [19] published a study of 1721 women undergoing a first IVF cycle with autologous embryos. Compared to normalweight women, women with a BMI more than 35 had fewer normally fertilized oocytes. Additionally, the odds of clinical pregnancy and live birth were 50% lower in women with BMI more than 40. Obese women also had significantly lower estrogen levels on the day of human chorionic gonadotropin administration despite having received similar amounts of gonadotropin.
Several studies demonstrate that obese women undergoing ART require longer durations of gonadotropin stimulation and increased amounts of gonadotropin than normal-weight women to produce a similar number of ovarian follicles [20] [21] [22] [23] . This may be the result of altered absorption and/or metabolism of gonadotropins, or steroidogenesis by the supporting cells of the ovarian follicle [19, 22] . There is also evidence that follicular leptin levels correlate with BMI [24, 25] , and high intrafollicular levels of leptin have been associated with relative gonadotropin resistance during ovarian stimulation in PCOS patients [26] .
In addition to the oocyte, it is important to consider the role of the early embryo. Embryo quality is affected by oocyte quality, and embryos derived from oocytes of obese women are of poorer quality than those derived from normal-weight women [27, 28] . Although animal models demonstrate obesity may impact the embryo directly, mechanistic human studies are lacking as data on human embryos are derived from clinical IVF studies in which women are using the embryos for fertility treatment [3] .
The endometrium
Although the ovarian follicle, the oocyte and the embryo are important targets for obesity, other studies highlight the endometrium's role in the pathophysiology of adverse reproductive outcomes among obese women [29] [30] [31] . Bellver et al. [32] have published a number of studies supporting a role for the endometrium in the pathophysiology of reproduction in obese women. These authors have previously demonstrated that the endometrium of obese women showed dysregulated genes related to biologic processes, such as development, morphogenesis, and the immune system, as well as different molecular functions, such as protein binding [32] . Some of these genes have been previously related to implantation and unexplained infertility.
Most recently, as discussed above, Bellver et al.
] published a study of 9587 first cycles of oocyte donors and showed that implantation, pregnancy, and live birth rates were significantly reduced as BMI increased. Bellver did not find a difference in miscarriage rates between the normal and obese patient groups, but several other retrospective studies have associated obesity with increased risk for miscarriage in spontaneous conceptions [33] , as well as in obese women receiving donor oocytes after IVF [34, 35] . A recent systematic review by Boots and Stephenson [36] also found an increased risk of miscarriage in obese women who conceive spontaneously [odds ratio (OR): 1.31; 95% CI, 1.18 to 1.46]. In a recent follow-up study, Boots et al. [37 & ] show that obese women with recurrent pregnancy loss have a higher rate of euploid miscarriage as compared with nonobese women with prolactin, 58 versus 37% (RR 1.63, 95% CI 1.08-2.47), again suggesting some issue beyond the oocyte or embryo contributing to the pathogenesis of reproduction in the setting of obesity. It is possible that in women undergoing ART, the exogenous gonadotropins, embryo culture, and selection may counter the abnormalities obesity poses on the reproductive process. If this is the case, it may explain why the relationship between obesity and miscarriage is less robust in women undergoing ART than it appears to be for spontaneous conception [38] .
Male obesity
The negative impact of male overweight and obesity on reproductive function is multifactorial and may be caused by altered hormonal profile, decreased sperm concentration and count, local heat, as well as sexual dysfunction. Obese men have decreased testosterone and gonadotropin levels and increased circulating estrogen levels [39] . The increase in estrogen is likely secondary to peripheral aromatization of androgens. As estrogen negatively feedbacks onto the hypothalamus, a hypogonadotropic hypogonad state is created leading to erectile dysfunction [39] . Although there is some debate as to whether sperm quality or motility is altered in obese men, most literature suggests lower sperm counts and concentration in obese men [40 & ]. Increase in local heat has been suggested as a possible mechanism for impaired spermatogenesis in obese men [41] .
Ramlau-Hansen et al. [42] analyzed data from the Danish National Birth Cohort to evaluate the effect of male BMI on time to pregnancy. Subfecundity was defined as waiting time of more than 12 months to achieve pregnancy. Data from 47 835 couples showed that couples with overweight (BMI 25-29.9) and obese (BMI>30) male partners were more likely to have subfecundity, with ORs of 1.15 (95% CI 1.09-1.22) and 1.49 (95% CI 1.34-1.64), respectively, after correction for female BMI and male and female age. Interestingly, among couples in which both partners were either overweight or obese, the adjusted ORs for subfecundity were 1.41 (95% CI: 1.28-1.56) and 2.74 (95% CI: 2.27-3.30), respectively, compared with normal-weight couples [42] . Nguyen et al. [43] performed a similar study incorporating 26 303 pregnancies from the Norwegian Mother and Child Cohort Study. Even after controlling for coital frequency and female BMI, age, and smoking, the odds of infertility were 1.20 (95% CI ¼ 1.04-1.38) for overweight men and 1.36 (95% CI ¼ 1.13-1.63) for obese men compared with normal-weight men [43] .
Petersen et al. [44 & ] recently used nationwide Danish register data to evaluate the influence of male and female BMI on live births after ART. Their study evaluated 25 191 IVF and intracytoplasmic sperm injection cycles in 12 566 couples. When evaluating normal-weight women with overweight or obese partners (BMI>25) undergoing IVF, a reduced live birth rate was observed, OR 0.78 (95% CI 0.52-1.16). The IVF-treated couples had reduced probability of live birth when both male and female partners were overweight or obese (BMI>25), with an adjusted OR of 0.73 (95% CI 0.48-1.11) [44 & ]. The trend of obesity in both partners compounding the negative influence on live birth rates after IVF was not seen when evaluating obese couples undergoing intracytoplasmic sperm injection suggesting that intracytoplasmic sperm injection technology may overcome obesity-related impairment of egg-sperm interaction.
Treatment approaches
In addition to increased risks of impaired reproductive function, obese women are at increased risk for adverse pregnancy outcomes, including preeclampsia, gestational diabetes, fetal growth abnormalities, stillbirth, congenital abnormalities, and the need for cesarean delivery [45, 46] . Because of these risks, clinicians often encourage obese women with subfertility to lose weight before they initiate fertility treatment. Some clinics even have BMI limits on whom they will treat [47] . As such, weight loss is often recommended as first line for managing obesity-related subfertility.
A recently published study by Kort et al. [48 & ] evaluated the effects of meaningful weight loss, defined as at least 10%, on conception rate, live birth rate, and spontaneous conception rate in 58 obese women undergoing infertility treatment. The results showed a statistically significant increase in conception rate, 88 versus 54% (P ¼ 0.049), for those with at least 10% weight loss and less than 10%, respectively. The live birth rate was 71 versus 37% (P ¼ 0.024) for those same groups. The spontaneous conception rate was higher in women with at least 10% weight loss, but the results were not statistically significant [48 & ]. In one of the only prospective studies regarding weight loss and reproductive outcomes, Clark et al. [49] demonstrated a 77% pregnancy rate (18 spontaneous pregnancies, 37 with fertility treatment) in 67 women who completed a lifestyle intervention program, as opposed to no pregnancies occurring in the 20 women who dropped out of the program demonstrating that women who are motivated to participate in weight-loss programs may improve their chances of conceiving. Although efficacious, weight-loss programs can be difficult for some women to adhere to. Bariatric surgery may offer a more clinically meaningful, sustainable weight loss. Not only does weight loss after bariatric surgery improve ovulation, but for women who conceive it also decreases risk of gestational diabetes and preeclampsia [50-52,53 & ].
Lifestyle changes resulting in weight loss are likely important, but even without weight loss physical activity may benefit obese women as Wise et al. [54] recently found that physical activity decreased time to pregnancy in overweight and obese women. Specific dietary components may also be important as Chavarro et al. [55] demonstrate using data from the Nurses' Health Study that diets high in saturated and trans-fat harm ovulation, whereas supplemental iron and folate are beneficial.
Although preconception weight loss is ideal, obese women who are older than 35 face a more significant challenge to fertility -age. After the age of 35, there is a decrease in the success of IVF in all women, regardless of BMI [56] . To help clinicians counsel subfertile, obese women, Sabounchi et al. [57 & ] recently published a model incorporating physiological, sociological, and sex-specific factors affecting weight gain and retention. This model may be used as a decision-making tool to help women move forward with weight-loss goals and fertility treatment.
CONCLUSION
It is important that obstetricians and gynecologists are aware of the pathophysiology of obesity in reproduction as obesity is common and not going away. In fact, the American College of Obstetricians and Gynecologists recently issued an opinion from the ethics committee stating that 'it is unethical for physicians to refuse to accept a patient or decline to continue care that is within their scope of practice solely because the patient is obese. However, if physicians lack the resources necessary for the safe and effective care of the obese patient, consultation or referral, or both are appropriate' [58] . Obese women with subfertility have often tried losing weight without success, and they are working within a window of time in which obesity risks must be weighed against age-related decline in fertility. Physicians need to be prepared to work with them. This is the largest study investigating obesity and chances of pregnancy after ART using donor oocytes. The donor oocyte model uses oocytes from healthy, young donors and is able to isolate the influence of obesity in the recipient. Thus, it may be ideal in investigating the influence of obesity on endometrial receptivity.
